Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.83), $0.08 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $7.5 million versus the consensus estimate of $1.25 million.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.